Olema Pharmaceuticals, Inc. OLMA Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s short- and long-term operating lease liabilities?
- Olema Pharmaceuticals, Inc. (OLMA) reported short- and long-term operating lease liabilities of -$313K in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
- Olema Pharmaceuticals, Inc.'s short- and long-term operating lease liabilities decreased by 1.3% year-over-year, from -$309K to -$313K.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s short- and long-term operating lease liabilities?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s short- and long-term operating lease liabilities has grown at a 5.9% compound annual growth rate (CAGR), from -$988K to -$1.24M.